Spot Trading’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$760K Sell
1,700
-6,500
-79% -$3.09M 0.01% 1343
2017
Q2
$4.03M Buy
8,200
+4,400
+116% +$1.93M 0.08% 304
2017
Q1
$1.47M Sell
3,800
-1,200
-24% -$445K 0.05% 511
2016
Q4
$1.83M Sell
5,000
-1,700
-25% -$646K 0.04% 610
2016
Q3
$2.69M Sell
6,700
-51,500
-88% -$20.7M 0.05% 506
2016
Q2
$20.3M Buy
58,200
+9,200
+19% +$3.54M 0.35% 25
2016
Q1
$17.7M Buy
49,000
+45,400
+1,261% +$18.7M 0.31% 36
2015
Q4
$1.95M Buy
3,600
+1,000
+38% +$542K 0.02% 1027
2015
Q3
$1.21M Hold
2,600
0.01% 1429
2015
Q2
$1.33M Sell
2,600
-10,200
-80% -$4.98M 0.01% 1434
2015
Q1
$5.78M Sell
12,800
-13,600
-52% -$5.76M 0.06% 482
2014
Q4
$10.8M Buy
26,400
+1,000
+4% +$393K 0.07% 366
2014
Q3
$9.16M Sell
25,400
-600
-2% -$201K 0.05% 577
2014
Q2
$7.34M Buy
26,000
+17,200
+195% +$5.1M 0.04% 731
2014
Q1
$2.64M Sell
8,800
-15,500
-64% -$4.78M 0.01% 1279
2013
Q4
$6.69M Buy
24,300
+5,800
+31% +$1.67M 0.04% 673
2013
Q3
$5.79M Buy
18,500
+2,500
+16% +$658K 0.04% 639
2013
Q2
$3.6M Buy
+16,000
New +$3.73M 0.02% 934

Other funds holding REGN

Spot Trading's REGN Position: Q3 2017 in Review

Spot Trading opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2017: 1,919 shares worth $858K. The stake represents 0.01% of the portfolio and ranks #1276 among its holdings. This is a return to the name: Spot Trading previously reported a position in REGN as recently as Q3 2016.

Spot Trading first reported a position in REGN in Q2 2013 and has held it in 10 quarters since. The position peaked at $1.84M in Q2 2016. 605 funds tracked by Wall St. Rank hold REGN as of Q3 2017.

  • Spot Trading held 1,919 shares of Regeneron Pharmaceuticals worth $858K as of Q3 2017.
  • Regeneron Pharmaceuticals was a new Spot Trading position in Q3 2017.
  • Regeneron Pharmaceuticals made up 0.01% of Spot Trading's portfolio in Q3 2017, its #1276 holding.
  • Spot Trading first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 10 quarters since.
  • Spot Trading's Regeneron Pharmaceuticals position peaked at $1.84M in Q2 2016.
  • 605 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.